Business · 23/05/1994Updated: 10/16/2026 · 1 min read
Astra USA, Inc., et al.; Withdrawal of Approval of 62 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 62 abbreviated new drug applications (ANDA's) due to the holders' request to stop marketing the associated drug products.
Original source language: Federal Register — Health and Human ServicesOpen original release →